Share on StockTwits

Investment analysts at Compass Point boosted their price objective on shares of Physicians Realty Trust (NYSE:DOC) from $16.00 to $16.50 in a note issued to investors on Thursday. Compass Point’s target price indicates a potential upside of 16.44% from the stock’s previous close.

A number of other firms have also recently commented on DOC. Analysts at Oppenheimer raised their price target on shares of Physicians Realty Trust from $14.00 to $15.50 in a research note on Monday. They now have an “outperform” rating on the stock. Separately, analysts at MLV & Co
initiated coverage on shares of Physicians Realty Trust in a research note on Friday, June 27th. They set a “buy” rating and a $16.00 price target on the stock. Finally, analysts at Bank of America initiated coverage on shares of Physicians Realty Trust in a research note on Monday, June 2nd. They set a “buy” rating and a $14.25 price target on the stock. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Physicians Realty Trust has an average rating of “Buy” and a consensus target price of $15.46.

Physicians Realty Trust (NYSE:DOC) traded up 0.46% during mid-day trading on Thursday, hitting $14.235. The stock had a trading volume of 27,553 shares. Physicians Realty Trust has a one year low of $11.00 and a one year high of $14.77. The stock’s 50-day moving average is $14.33 and its 200-day moving average is $13.61. The company’s market cap is $303.2 million.

Physicians Realty Trust (NYSE:DOC) last released its earnings data on Wednesday, August 13th. The company reported $0.17 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.23 by $0.06. The company had revenue of $11.40 million for the quarter, compared to the consensus estimate of $10.40 million. On average, analysts predict that Physicians Realty Trust will post $0.87 earnings per share for the current fiscal year.

Physicians Realty Trust is a real estate investment trust (NYSE:DOC).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.